Actemra 80 mg Injection
91.93$
78.77$
Actemra 80 mg injection is a potent therapeutic option designed to address multiple inflammatory conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriasis, ulcerative colitis, and Crohn's disease. As a monoclonal antibody and disease-modifying anti-rheumatic drug (DMARD), Actemra functions by targeting and inhibiting the activity of tumor necrosis factor-alpha (TNFα), a key contributor to inflammation. This innovative treatment effectively alleviates symptoms such as swelling, pain, and redness, significantly enhancing the quality of life for patients. By improving physical function, Actemra empowers individuals to engage more fully in daily activities. However, it is essential to note that this medication may increase the risk of serious infections, so close monitoring by healthcare professionals is crucial during treatment. Patients are advised to discuss their complete medical history and any existing health concerns before starting therapy with Actemra. With its targeted action and proven efficacy, Actemra 80 mg injection stands out as a valuable tool in the management of debilitating autoimmune diseases.
الكمية
Active Pharmaceutical Ingredient
Uses
• Actemra 80 mg injection is commonly used to treat moderate to severe rheumatoid arthritis in adults. This medication helps reduce inflammation and pain associated with the condition, enabling patients to regain mobility and improve their quality of life. It is often prescribed when other treatments have not been effective. By targeting specific pathways in the immune system, Actemra 80 mg injection aids in managing symptoms effectively.
• In cases of juvenile idiopathic arthritis, Actemra 80 mg injection is utilized to alleviate symptoms in children aged two years and older. This treatment works by inhibiting interleukin-6, a key player in the inflammatory process. As a result, it helps decrease joint swelling and pain, allowing young patients to participate more fully in daily activities. The use of Actemra 80 mg injection can be crucial for managing this chronic condition.
• Actemra 80 mg injection is also indicated for the treatment of giant cell arteritis, a condition characterized by inflammation of the blood vessels. By reducing inflammation, this medication helps prevent complications associated with the disease, such as vision loss. Patients receiving Actemra 80 mg injection often report improved overall health and reduced symptoms. Regular administration can be essential for long-term management of giant cell arteritis.
• For patients with severe forms of systemic juvenile idiopathic arthritis, Actemra 80 mg injection serves as a vital therapeutic option. It helps control systemic inflammation and associated symptoms, providing relief to affected children and adolescents. By targeting the underlying immune response, Actemra 80 mg injection can significantly enhance the quality of life for young patients. This treatment is an important part of managing this challenging condition.
Benefits
Rheumatoid arthritis: Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. It causes inflammation, pain, stiffness, and swelling in the joints, and can also affect other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. Actemra 80 mg helps reduce inflammation and manage the symptoms of Rheumatoid arthritis.
Ankylosing spondylitis: Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine, causing pain, stiffness, and reduced mobility. It is a form of arthritis that mainly affects the joints between the vertebrae in the spine and the sacroiliac joints where the spine connects to the pelvis. Actemra Injection works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing the inflammation associated with ankylosing spondylitis, Actemra 80 mg Injection can help relieve pain, stiffness, and other symptoms of the condition.
Crohn's disease: Crohn's disease is a chronic inflammatory bowel disease (IBD) that primarily affects the gastrointestinal tract. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Symptoms of Crohn's disease can vary but commonly include abdominal pain, diarrhoea, weight loss, fatigue, and loss of appetite. Actemra 80 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the gastrointestinal tract, Actemra 80 mg Injection can help manage the symptoms of Crohn's disease, including abdominal pain, diarrhoea, and inflammation.
Ulcerative colitis: Ulcerative colitis is a chronic inflammatory bowel disease that primarily affects the colon and rectum. Actemra Injection can help reduce inflammation in the gastrointestinal tract and manage the symptoms of ulcerative colitis.
Hidradenitis suppurativa: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that affects the hair follicles in areas of the body with a high concentration of sweat glands, such as the armpits, groin, and buttocks. Actemra 80 mg works by targeting and inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation, Actemra 80 mg Injection can help alleviate symptoms and prevent the progression of hidradenitis suppurativa.
Juvenile idiopathic arthritis: Juvenile idiopathic arthritis (JIA) is a type of arthritis that occurs in children under the age of 16 and persists for at least six weeks. It is characterized by joint inflammation, pain, stiffness, and swelling. Actemra 80 mg Injection works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab helps manage the symptoms of Juvenile idiopathic arthritis, including pain, stiffness, and swelling. Plaque psoriasis: Psoriasis is a condition where the skin cells in the body grow too quickly and form scales and dry patches. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back. Actemra Injection reduces the scaly, itchy patches which may develop on the different parts of the body. It may take several months to become fully effective. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Psoriatic arthritis: Psoriatic arthritis is a type of inflammatory arthritis that occurs in some individuals with psoriasis, a chronic skin condition. It causes joint pain, swelling, and stiffness, and can affect any joint in the body. Actemra 80 mg Injection works by inhibiting tumour necrosis factor (TNF), a protein involved in inflammation. By reducing inflammation in the joints, adalimumab can help manage the symptoms of psoriatic arthritis, including joint pain, stiffness, and swelling.
Uveitis: Uveitis refers to the inflammation of the uvea, which is the middle layer of the eye. It can affect various parts of the uvea, including the iris, ciliary body, and choroid. Actemra 80 mg is a tumour necrosis factor (TNF) inhibitor that helps reduce inflammation by targeting TNF, a protein involved in the immune response.
Side Effects
As with all medicines, Actemra 80 mg Injection may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Most Common Side Effects
• Diarrhoea
• Headache
• Throat, Nasal and Chest infections
• Skin infections
• Tiredness
• Yellow Eyes and Skin.
• Appetite loss
• Vomiting
• Darker Urine and Tarry stool
• skin rashes
• Short breathing
• Chest pain
• Coughing and Sneezing with blood and Mucus
• redness and Swelling of Skin
• painful Urination
• Weigh loss
• Changes in Frequency and Consistency of passing stool.
Common Side Effects
• Blood Clots
• sudden shortness of Breath
• Painful Breathing
• Chest Pain
• Heavy Sweating
• Redness, Painful and Swollen limbs.
How To Use
Actemra 80 mg Injection is given subcutaneously (under the skin) from any health care professional. Dosage and frequency will be decided by your doctor as per your disease condition and several other factors.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Actemra 80 Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Actemra 80 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Actemra 80 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: Actemra 80 mg is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
• Liver: Actemra 80 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Actemra 80 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Actemra 80 Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Actemra Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects on the developing baby; however, there are limited human studies.
• Driving: Actemra 80 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Actemra 80 mg.